National Influenza Sentinel Surveillance Viet Nam: 2006-2007 US CDC Collaboration and WHO Global Surveillance Network Partnership Nguyen Thanh Chung, MD,

Slides:



Advertisements
Similar presentations
Surveillance in a Pandemic: Situational Awareness
Advertisements

H3N2 variant influenza A Maine, 2011 Sara Robinson, MPH Epidemiologist Maine Center for Disease Control and Prevention.
Influenza Surveillance In Saskatchewan Ken Brandt Manager, Virology Section Provincial Laboratory Regina, Saskatchewan.
Public health assessment Avian flu A(H5N1) situation Feb 9, 2004.
Influenza-like Illness Visits & Influenza Labs as of December 10, 2012.
CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION Influenza Surveillance in Mainland of China Yuelong Shu Chinese National Influenza Center National Institute.
Lisa Grohskopf, MD, MPH Medical Officer Influenza Division Centers for Disease Control and Prevention U.S. Influenza Surveillance National Center for Immunization.
Role of the laboratory in disease surveillance
AVIAN INFLUENZA (A/H5N1) SITUATION IN VIETNAM, National Institute of Hygiene and Epidemiology.
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
CDC Director’s Perspective Immunization Program Managers Meeting Thomas R. Frieden, MD, MPH Director, CDC Administrator, ATSDR.
Pandemic Influenza Preparedness Kentucky Department for Public Health Department for Public Health.
HealthSanté CanadaCanada Influenza Prevention and Control in Canada Arlene King, MD, MHSc, FRCPC Director, Immunization and Respiratory Infections Division,
1 Situation of Current ARV Treatment in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Influenza Surveillance at IRID Immunization and Respiratory Infections Division Centre for Infectious Disease Prevention & Control Public Health Agency.
Texas Influenza Surveillance Lesley Bullion Influenza Surveillance Coordinator Infectious Disease Control Unit.
WHO COLLABORATION | September 13, | WHO Indonesia Collaboration with Animal Health.
Pandemic Influenza. Guidance for Pandemic Influenza: Infection Control in Hospitals and Primary Care Settings UK Pandemic Influenza Contingency Plan Operational.
The Profile of Vietnam health sector & current Surveillance capacity of the infectious Diseases in Vietnam MBDS Vietnam.
Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.
Surveillance Activities during Pandemic Phases Anne-Luise Winter APHEO-COMOH Workshop Toronto February 1, 2007.
1 INFLUENZA (AND OTHER RESPIRATORY VIRUS) SURVEILLANCE IN WISCONSIN Thomas Haupt M.S. Wisconsin Influenza Surveillance Coordinator.
Influenza-like Illness Surveillance at the National Level
Centers for Disease Control and Prevention Program title: Developing sustainable surveillance and response for seasonal and avian influenza. Goal: To establish.
Public Health Issues of Interest Seasonal Influenza Seasonal Norovirus Middle East Respiratory Syndrome Coronavirus Novel Influenza (A/H7N9) David H. Trump,
Outbreak of influenza A (H3N2) in a residence for mentally disabled persons in Ljubljana, Slovenia, 2013 Epidemiology and Public Health Valencia, Spain.
U.S. Influenza Surveillance Keiji Fukuda Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.
Influenza Surveillance Update Health and Medical Subpanel Meeting July 13, 2010 Diane Woolard, VDH.
Dr. Zhen XU Branch of Respiratory Disease Prevention and Control Division for Disease Control and Emergency Response Chinese Center for Disease Control.
Influenza and the Nursing Home Population Julie L. Freshwater, PhD MPH Influenza Surveillance Coordinator 1.
Papua New Guinea Update 3 rd NIC Meeting 18 – 20 Beijing, China Berry Ropa National CSR Officer Department of Health Papua New Guinea.
World Health Organization, Regional Office for The Western Pacific Regional Activities Report and Preparation for the Upcoming Influenza Seasons THE 3rd.
Pandemic Response and current activities in Lao PDR NIC Meeting, Beijing, Aug 2009 Dr Phengta Vongphrachanh Director National centre for Laboratory.
Texas Influenza Surveillance Lesley Bullion Influenza Surveillance Coordinator Infectious Disease Control Unit.
Laboratory Integration in Influenza Surveillance Dr Geethani Wickramasinghe NIC- Sri Lanka.
US Situation Update and CDC International Response H1N1 Pandemic US Situation Update and CDC International Response Peter Nsubuga, MD, MPH On behalf of.
1 Novel Influenza A H1N1 Outbreak: The Florida Response Epidemiology Perspective: Situation Update.
1 Using ESSENCE-FL and a serosurvey to estimate total influenza infections, 2009 Richard S. Hopkins, MD, MSPH Kate Goodin, MPH Mackenzie Weise, MPH Aaron.
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
Communicable Disease Surveillance and Response, WHO Avian Influenza Credit: WHO Viet Nam.
Introduction for Basic Epidemiological Analysis for Surveillance Data National Center for Immunization & Respiratory Diseases Influenza Division.
1 Division of Health Security and Emergencies (DSE) WHO Western Pacific Regional Office (WPRO) Fifth Meeting of National Influenza Centres in the Western.
Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School.
THE DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORK IN THE PHILIPPINES (June 2005 – March 2008)‏ Remigio M. Olveda 1, Enrique A. Tayag 2, Analisa N. Bautista.
It’s Just Not the Flu Anymore Rick Hong, MD Associate Chairman CCHS EMC Medical Director, PHPS.
U.S. Outpatient Influenza-Like Illness Surveillance Network (ILINet) Neil Pascoe for Irene Brown.
Influenza Surveillance in the United States Oliver Morgan, PhD MSc Division of Emerging Infections and Surveillance Services Dr. Lyn Finelli, Scott Epperson.
1 Scaling-up ARV therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS The acquired HIV drug resistance among HIV adults receiving ART at least 36 months in Vietnam Vũ Quốc.
Washington State Department of Health Influenza Surveillance Update Vivian Hawkins, MS PhD Washington State Department of Health Communicable Disease Epidemiology.
ASDPE Regional Plan for Strengthening the National Influenza Surveillance Capacity: Guiding the way towards a comprehensive National Influenza Surveillance.
Current Pandemic H1N1 Updates in the Philippines Department of Health, Philippines Juan M. Lopez, MD, PGradDipPH, MPH Aldrin Q. Reyes, RN.
Seoul Metropolitan Government Health & Welfare Headquarters Health Policy Division Kui-Nam Kim.
U.S. Influenza Surveillance Ann Moen Influenza Branch NCID/CDC.
PANDEMIC H1N1 IN HANOI-VIETNAM: OVERVIEW AND RESPONSE.
CVD Testing the H1N1 Pandemic Flu Vaccines Mini-Med School Karen Kotloff, MD University of Maryland School of Medicine Center for Vaccine Development September.
Correlation of National Influenza Surveillance Data to the Local Experience Kate Goodin, MPH Florida Department of Health Bureau of Epidemiology 6 th Annual.
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China Qun Li, M.D., Lei Zhou, M.D., Minghao Zhou, Ph.D., Zhiping Chen, M.D., Furong.
Influenza Virologic Surveillance and Vaccine Strain Selection Xiyan Xu MD Deputy Director WHO Collaborating Center for Surveillance, Epidemiology and Control.
1. Globalization High Mobility of Human Globalization of infectious disease outbreaks Lessons from Pandemic (H1N1) 2009 Concern of next pandemic due to.
Flu Update and Overview of Flu Surveillance in RI
Infectious Diseases Surveillance in the Military
U.S. Influenza Surveillance Sabrina Swenson, dvm ms phd
Establishment of Influenza Surveillance System in Liberia
Maintaining Canada’s FluWatch Influenza-like Illness (ILI) surveillance system - Challenges and Opportunities Dr. Christina Bancej, Public Health Agency.
Influenza-like Illness Surveillance at the National Level
The Role of NICs in Influenza Surveillance
DEPARTMENT OF MEDICINE, UOM
U.S. Influenza Sentinel Provider Surveillance Network
Varicella Vaccine Efficacy Estimates
Presentation transcript:

National Influenza Sentinel Surveillance Viet Nam: US CDC Collaboration and WHO Global Surveillance Network Partnership Nguyen Thanh Chung, MD, NIHE

National reports of ILI

General objectives Obtain epidemiological and virological information to guide influenza prevention and control policies and activities Obtain epidemiological and virological information to guide influenza prevention and control policies and activities Establish a sustainable national influenza surveillance network in Vietnam Establish a sustainable national influenza surveillance network in Vietnam

Specific Objectives  Determine influenza impact and seasonality  Rapidly detect outbreaks  Monitor circulating strains  Contribute to influenza prevention and control  Contribute to global surveillance and selection of virus strains for vaccine production

Organization NIHE Regional Institutes VAPM PMCs MOH Sentinel Sites CDC/WHO partners

Organizational network of Institutes and sentinel sites NIITD dAK LAK tHAI BINH HCMc TDH HCMC PH #1 BA TRIEU Moh/CDC/who/NIHE KHANH HOA TAY NGUYEN HCMC NIHE Tt. HUE LANG SON HOA BINH NPH THANH XUAN dONG NAI TIEN GIANG DA NANG CITY NHATRANG

Sentinel site characteristics   Major ecological regions represented   Adult and pediatric populations served   Different levels of health services Central referral hospitals Provincial hospitals District hospitals Polyclinics / health centers

Case definition ILI (WHO)  Sudden onset of fever >38°C  Cough and/or sore throat  Absence of another diagnosis  Onset illness within 3 days for cases selected for PCR testing

ILI surveillance methods   Total patient and ILI consultations recorded weekly at each site   First 2 ILI patients each day sampled for investigation   Throat swab collected and transported to regional laboratory   RT-PCR testing at regional laboratories   Virus sub-typing and isolations made if PCR +

ILI surveillance Results

Total and ILI outpatient visits by sentinel site No.Sentinel Site Total Number Patient Visits Number ILI Patient Visits Percent ILI Visits (%) 01NIITD, Hanoi ,8 02Natl. Ped. Hosp., Hanoi ,2 03Ped. Hosp. #1, HCMC ,5 04Hosp. Trop. Dis., HCMC ,4 05Khanh Hoa Prov. Hospital ,6 06Dac Lac Prov. Hospital ,4 07Kien Xuong Dist. Hospital ,4 08Hoa Binh Dist. Hospital ,4 09Cao Loc Dist. Hospital ,8 10Huong Thuy Dist. Hospital ,9 11Ba Trieu Clinic, Hanoi ,6 12Thanh Xuan Clinic, Hanoi Thanh Khe Dist. Hospital ,1 14Xuan Loc Dist. Hospital ,1 15Cai Be Dist. Hospital ,5 All sentinel sites ,6 Sites no. 08, 09, 11 and 12 initiated surveillance on June, 1st 2006 Sites no. 13, 14, and 15 initiated surveillance on June, 1st 2007

RT-PCR positive ILI cases, by sentinel sites No. Sentinel site Number ILI patients tested Number (%) A/H1 positive Number (%) A/H3 positive Number (%) A undeter- mined Number (%) Influenza B positive Number (%) total Influenza Positive 01NIITD, Hanoi (7.6)56 (9)063 (10.1)166 (26.7) 02Natl. Ped. Hosp., Hanoi (8.7)97 (11.2)169(7.9)243(28.0) 03Ped. Hosp. #1, HCMC (6.9)90(9.0)077(7.7)236(23.6) 04Hosp. Trop. Dis., HCMC 99939(3.9)23(2.3)052(5.2)114(11.4) 05Khanh Hoa Prov. Hospital (5.3)88(8.8)256(5.6)199(19.9) 06Dac Lac Prov. Hospital (2.7)63(6.3)062(6.2)152(15.2) 07Kien Xuong Dist. Hospital (3.7)58(5.8)059(5.9)154(15.4) 08Hoa Binh Dist. Hospital 80154(6.7)71(8.9)012(1.5)137(17.1) 09Cao Loc Dist. Hospital 68242(6.2)43(6.3)012(1.8)97(14.2) 10Huong Thuy Dist. Hospt (6.6)81(9.7)044(5.3)180(21.6) 11Ba Trieu Clinic, Hanoi 62840(6.4)60(9.6)014(2.2)114(18.2) 12Thanh Xuan Clinic, Hanoi 77843(5.5)105(13.5)012(1.5)160(20.6) 13Thanh Khe Dist. Hospital 3098(2.6)47(15.2)014(4.5)69(22.3) 14Xuan Loc Dist. Hospital 2780(0.0)33(11.9)025(9.0)58(20.9) 15Cai Be Dist. Hospital 2800(0.0)19(6.8)014(5.0)33(11.8) All sites (5.3)934(8.4)3585(5.3)2112(19.1) Sites no. 08, 09, 11 and 12 initiated surveillance on June, 1st 2006 Sites no. 13, 14, and 15 initiated surveillance on June, 1st 2007

Influenza percent positive by region

Influenza types/subtypes circulating in Viet Nam, (N=2112 virus detections)

Percent of ILI testing positive for influenza A/H1N1, by month and region

H1N1 subtype, 2007 Results of Sequencing H1N1 subtype in 2007 had 99% homology with A/Solomon Islands/3/2006 subtype H1N1 subtype in 2007 had 99% homology with A/Solomon Islands/3/2006 subtype H1N1 subtypes isolated in Vietnam were homologous with the subtype selected for flu vaccine production in 2007 H1N1 subtypes isolated in Vietnam were homologous with the subtype selected for flu vaccine production in 2007

Percent of ILI testing positive for influenza A/H3N2, by month and region

H3N2 subtype, 2007 H3N2 subtype in 2007 showed 99% sequencing homology with A/California/UR /2007 subtype H3N2 subtype in 2007 showed 99% sequencing homology with A/California/UR /2007 subtype H3N2 subtypes isolated in 2007 in Vietnam differed from the subtype used for flu vaccine production in H3N2 subtypes isolated in 2007 in Vietnam differed from the subtype used for flu vaccine production in 2007.

Percent of ILI testing positive for influenza B, by month and region

B flu virus subtype, 2007 B subtype in 2007 showed 99% sequencing homology with B/Florida/02/2006 subtype B subtype in 2007 showed 99% sequencing homology with B/Florida/02/2006 subtype B subtypes isolated in Vietnam in 2007 were homologous with the virus used for vaccine production in B subtypes isolated in Vietnam in 2007 were homologous with the virus used for vaccine production in 2007.

ILI results summary  ILI is a major health care burden  High proportion ILI cases are influenza  Influenza detected all times of year, in all regions, at all sites  All common subtypes endemic  Seasonal fluctuations occur in subtype activity  Regional synchrony subtype activity observed

Challenges  Achieve greater efficiency, sustainability  Apply results to policies and practices  Capabilities strengthening needed all levels  Strengthen lab and epidemiology ties  Strengthen links human and animal sectors  Increase scientific collaborations, publications  Increase role in WHO Global Network

Thank You